Skip to main content
Top
Published in: Arthritis Research & Therapy 3/2002

01-04-2002 | Announcement

Arthritis Research: the move to publish research articles in full online only

Authors: Peter E Lipsky, Ravinder N Maini

Published in: Arthritis Research & Therapy | Issue 3/2002

Login to get access

Excerpt

When Arthritis Research was launched in 1999 the publishers and ourselves took the innovative decision to make all primary research articles available to everyone for free through the journal's own website http://​arthritis-research.​com as well as through PubMed Central http://​www.​pubmedcentral.​nih.​gov/​, the National Institute of Health's repository for biomedical research articles, and through the BioMed Central (BMC) website http://​biomedcentral.​com. We now feel that it is time to lead the way forward again by only publishing research articles in full online beginning with volume 4 number 4 of Arthritis Research. …
Metadata
Title
Arthritis Research: the move to publish research articles in full online only
Authors
Peter E Lipsky
Ravinder N Maini
Publication date
01-04-2002
Publisher
BioMed Central
Published in
Arthritis Research & Therapy / Issue 3/2002
Electronic ISSN: 1478-6362
DOI
https://doi.org/10.1186/ar397

Other articles of this Issue 3/2002

Arthritis Research & Therapy 3/2002 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine